Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome Cemil Kaya, M.D., Aycan Fahri Erkan, M.D., S. Dinçer Cengiz, M.D, Ilkkan Dünder, M.D., Özlem Erbaş Demirel, M.D., Ayşe Bilgihan, M.D. Fertility and Sterility Volume 92, Issue 4, Pages 1372-1377 (October 2009) DOI: 10.1016/j.fertnstert.2008.08.016 Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions
Figure 1 The serum levels of advanced oxidation protein products (AOPPs) in women with polycystic ovary syndrome (PCOS) and control women. Data are shown as mean ± SD. Fertility and Sterility 2009 92, 1372-1377DOI: (10.1016/j.fertnstert.2008.08.016) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions
Figure 2 Correlation between the carotid intima-media thickness (IMT) and advanced oxidation protein products (AOPPs), including all of the the patients. Data are shown as mean ± SD. Fertility and Sterility 2009 92, 1372-1377DOI: (10.1016/j.fertnstert.2008.08.016) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions